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ABSTRACT
In 2005, draft guidelines were published for reporting
studies of quality improvement interventions as the initial
step in a consensus process for development of a more
definitive version. This article contains the full revised
version of the guidelines, which the authors refer to as
SQUIRE (Standards for QUality Improvement Reporting
Excellence). This paper also describes the consensus
process, which included informal feedback from authors,
editors and peer reviewers who used the guidelines;
formal written commentaries; input from a group of
publication guideline developers; ongoing review of the
literature on the epistemology of improvement and
methods for evaluating complex social programmes; a
two-day meeting of stakeholders for critical discussion
and debate of the guidelines’ content and wording; and
commentary on sequential versions of the guidelines from
an expert consultant group. Finally, the authors consider
the major differences between SQUIRE and the initial draft
guidelines; limitations of and unresolved questions about
SQUIRE; ancillary supporting documents and alternative
versions that are under development; and plans for
dissemination, testing and further development of
SQUIRE.
A great deal of meaningful and effective work is
now done in clinical settings to improve the
quality and safety of care. Unfortunately, relatively
little of that work is reported in the biomedical
literature, and much of what is published could be
more effectively presented. Failure to publish is
potentially a serious barrier to the development of
improvement in health and medical care and
improvement science generally, since public shar-
ing of concepts, methods and findings is essential
to the progress of all scientific work, both
theoretical and applied. In an effort to strengthen
the evidence base for improvement in health care,
in 2005 we proposed draft guidelines for reporting
planned original studies of improvement interven-
tions.
1 Our ultimate aims were to stimulate the
publication of high-calibre improvement studies,
and to increase the completeness, accuracy and
transparency of published reports of that work.
Inadequate reporting of work in clinical
improvement has been documented in several
ways.
23 For example, a recent meta-regression
analysis of improvement strategies for diabetes
control concluded that ‘‘complexity of the inter-
vention … compounded by the paucity of descrip-
tive detail in most studies, may have resulted in
misclassification of interventions’’.
3 Moreover, an
informal study carried out following publication of
the draft guidelines found that only 12–68% of 30
published original reports of quality improvement
projects provided full information on the indivi-
dual guideline items we had identified,
1 while
individual guideline items were not addressed at
all in 4–44% of those reports (Mooney S, Ogrinc G,
unpublished).
Our initial draft guidelines were, of course, not a
tested approach to judging the quality of the
improvement literature, since that draft was based
largely on the authors’ personal experience with
improvement work, and was intended only as an
initial step towards an established standard. We
have now refined and extended that draft, as
planned. In the current article we present a revised
version, which we refer to as the Standard for
QUality Improvement Reporting Excellence, or
SQUIRE (table 1). We also describe the SQUIRE
consensus development process; the major differ-
ences between the current version of SQUIRE and
the initial draft guidelines; limitations of and
questions about SQUIRE; ancillary supporting
documents and variant versions that are under
development; and plans for dissemination, testing
and further development of the SQUIRE guide-
lines.
THE CONSENSUS PROCESS
The SQUIRE development process proceeded along
six general lines. First, we obtained informal
feedback on the utility, strengths and limitations
of the initial draft guidelines by using them in
seminars with potential authors in both the United
States and other countries; others have gathered
similar information from journal reviewers.
4 We
obtained additional comment at the organisational
meeting of the EQUATOR Network, a group of
experienced publication guideline developers, in
June 2006.
5 Second, journal editors and authors
‘‘road tested’’ the draft guidelines as an aid to
writing and editing submitted manuscripts. In that
connection, at the time of writing this paper the
2005 article
1 has been cited in approximately 40
subsequent publications, and full text or PDF
copies have been downloaded from the journal
website over 15 000 times. Third, we solicited
formal commentaries by several knowledgeable
authors on the initial version of the guidelines.
6–10
Fourth, we conducted an ongoing review of the
relevant literature on epistemology, methodology
and evaluation of complex interventions, particu-
larly in social sciences and the evaluation of social
programmes. Fifth, in April 2007 we subjected the
draft guidelines to intensive analysis, comment and
recommendations for change at a two-day meeting
of 30 stakeholders. Finally, following that meeting,
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Text section; item number and name Section or item description
Title and abstract Did you provide clear and accurate information for finding, indexing, and scanning your paper?
1 Title (a) Indicates the article concerns the improvement of quality (broadly defined to include the safety, effectiveness, patient-centredness,
timeliness, efficiency and equity of care)
(b) States the specific aim of the intervention
(c) Specifies the study method used (for example, ‘‘A qualitative study,’’ or ‘‘A randomised cluster trial’’)
2 Abstract Summarises precisely all key information from various sections of the text using the abstract format of the intended publication
Introduction Why did you start?
3 Background knowledge Provides a brief, non-selective summary of current knowledge of the care problem being addressed, and characteristics of organisations in
which it occurs
4 Local problem Describes the nature and severity of the specific local problem or system dysfunction that was addressed
5 Intended improvement (a) Describes the specific aim (changes/improvements in care processes and patient outcomes) of the proposed intervention
(b) Specifies who (champions, supporters) and what (events, observations) triggered the decision to make changes, and why now (timing)
6 Study question States precisely the primary improvement-related question and any secondary questions that the study of the intervention was designed to
answer
Methods What did you do?
7 Ethical issues Describes ethical aspects of implementing and studying the improvement, such as privacy concerns, protection of participants’ physical
wellbeing and potential author conflicts of interest, and how ethical concerns were addressed
8 Setting Specifies how elements of the local care environment considered most likely to influence change/improvement in the involved site or sites
were identified and characterised
9 Planning the intervention (a) Describes the intervention and its component parts in sufficient detail that others could reproduce it
(b) Indicates main factors that contributed to choice of the specific intervention (for example, analysis of causes of dysfunction; matching
relevant improvement experience of others with the local situation)
(c) Outlines initial plans for how the intervention was to be implemented—for example, what was to be done (initial steps; functions to be
accomplished by those steps; how tests of change would be used to modify intervention) and by whom (intended roles, qualifications,
and training of staff)
10 Planning the study of the
intervention
(a) Outlines plans for assessing how well the intervention was implemented (dose or intensity of exposure)
(b) Describes mechanisms by which intervention components were expected to cause changes, and plans for testing whether those
mechanisms were effective
(c) Identifies the study design (for example, observational, quasi-experimental, experimental) chosen for measuring impact of the
intervention on primary and secondary outcomes, if applicable
(d) Explains plans for implementing essential aspects of the chosen study design, as described in publication guidelines for specific designs,
if applicable (see, for example, www.equator-network.org)
(e) Describes aspects of the study design that specifically concerned internal validity (integrity of the data) and external validity
(generalisability)
11 Methods of evaluation (a) Describes instruments and procedures (qualitative, quantitative or mixed) used to assess (a) the effectiveness of implementation, (b) the
contributions of intervention components and context factors to effectiveness of the intervention and (c) primary and secondary outcomes
(b) Reports efforts to validate and test reliability of assessment instruments
(c) Explains methods used to assure data quality and adequacy (for example, blinding; repeating measurements and data extraction; training
in data collection; collection of sufficient baseline measurements)
12 Analysis (a) Provides details of qualitative and quantitative (statistical) methods used to draw inferences from the data
(b) Aligns unit of analysis with level at which the intervention was implemented, if applicable
(c) Specifies degree of variability expected in implementation, change expected in primary outcome (effect size) and ability of study design
(including size) to detect such effects
(d) Describes analytical methods used to demonstrate effects of time as a variable (for example, statistical process control)
Results What did you find?
13 Outcomes (a) Nature of setting and improvement intervention
(i) Characterises relevant elements of setting or settings (for example, geography, physical resources, organisational culture, history of
change efforts) and structures and patterns of care (for example, staffing, leadership) that provided context for the intervention
(ii) Explains the actual course of the intervention (for example, sequence of steps, events or phases; type and number of participants at key
points), preferably using a time-line diagram or flow chart
(iii) Documents degree of success in implementing intervention components
(iv) Describes how and why the initial plan evolved, and the most important lessons learned from that evolution, particularly the effects of
internal feedback from tests of change (reflexiveness)
(b) Changes in processes of care and patient outcomes associated with the intervention
(i) Presents data on changes observed in the care delivery process
(ii) Presents data on changes observed in measures of patient outcome (for example, morbidity, mortality, function, patient/staff
satisfaction, service utilisation, cost, care disparities)
(iii) Considers benefits, harms, unexpected results, problems, failures
(iv) Presents evidence regarding the strength of association between observed changes/improvements and intervention components/
context factors
(v) Includes summary of missing data for intervention and outcomes
Continued
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three cycles of a Delphi process involving an international group
of more than 50 consultants.
Informal feedback
Informal input about the draft guidelines from authors and peer
reviewers generally recognised their practical value, in com-
ments such as ‘‘These guidelines … can guide the writing of the
article, so it may be prudent to distribute [them] to the authors
of papers,’’ and ‘‘I … have used them and find them most
helpful’’.
4 These users also raised several relevant issues,
including (1) uncertainty as to when (that is, to which studies)
the guidelines apply, (2) the possibility their use might force QI
reports into a rigid, narrow format, (3) the concern that their
slavish application might result in unduly lengthy reports that
were indiscriminately laden with detail and (4) difficulty for
authors in knowing whether, and how, other guidelines (such as
the CONSORT guidelines for reporting randomised trials)
should be used in conjunction with guidelines for reporting
studies of improvement and safety.
Deciding when to use the guidelines
Publications on improvement in health care appear to be
emerging in four general categories: empirical studies on
development and testing of quality improvement interventions;
stories, theories and frameworks; literature reviews and
syntheses; and the development and testing of improvement-
related tools (Rubenstein L, et al, unpublished). Within that
context, our consensus process has made it clear that the
SQUIRE guidelines can and should apply to reporting in the
first category: formal planned empirical studies on the develop-
ment and testing of improvement interventions.
Forcing articles into a rigid format
Publication guidelines are often referred to as checklists, since
they serve the function of ‘‘aides-memoires’’ whose value in
managing information in highly complex systems is increasingly
appreciated.
11 Like all constraints, checklists can of course be
rigidly applied, a form of misuse that prevents rather than helps
to make sense of what is being reported.
12 13 Paradoxically,
constraints also serve as a crucial driver for creativity; as stated
by the 19th century English writer and designer William Morris:
‘‘You can’t have art without resistance in the materials’’. The
SQUIRE guidelines, like all form and structure, must therefore
always be understood and used as signposts, not shackles.
14 This
caution probably translates best into practice if authors simply
keep the guidelines in mind as a general framework while
writing their initial draft, and then use them for detailed critical
appraisal of what they’ve written while they revise the text.
Creating longer articles
Improvement is a complex undertaking, and its evaluation can
produce substantial amounts of qualitative and quantitive
information. Added length can therefore meet a principal aim
of SQUIRE if it makes reports of improvement studies more
complete, coherent, usable, and systematic; of course, adding
irrelevant information simply to ‘‘cover’’ guideline items
distorts that purpose. Publishing portions of improvement
studies electronically is one important way to make the content
of long papers publicly available while preserving the scarce
resource of print publication.
Conjoint use with other publication guidelines
Most other biomedical publication guidelines apply to the
reporting of specific study designs (for example, randomised
Table 1 Continued
Text section; item number and name Section or item description
Discussion What do the findings mean?
14 Summary (a) Summarises the most important successes and difficulties in implementing intervention components, and main changes observed in care
delivery and clinical outcomes
(b) Highlights the study’s particular strengths
15 Relation to other evidence Compares and contrasts study results with relevant findings of others, drawing on broad review of the literature; use of a summary table
may be helpful in building on existing evidence
16 Limitations (a) Considers possible sources of confounding, bias or imprecision in design, measurement, and analysis that might have affected study
outcomes (internal validity)
(b) Explores factors that could affect generalisability (external validity)—for example, representativeness of participants; effectiveness of
implementation; dose-response effects; features of local care setting
(c) Addresses likelihood that observed gains may weaken over time, and describes plans, if any, for monitoring and maintaining
improvement; explicitly states if such planning was not done
(d) Reviews efforts made to minimise and adjust for study limitations
(e) Assesses the effect of study limitations on interpretation and application of results
17 Interpretation (a) Explores possible reasons for differences between observed and expected outcomes
(b) Draws inferences consistent with the strength of the data about causal mechanisms and size of observed changes, paying particular
attention to components of the intervention and context factors that helped determine the intervention’s effectiveness (or lack thereof)
and types of settings in which this intervention is most likely to be effective
(c) Suggests steps that might be modified to improve future performance
(d) Reviews issues of opportunity cost and actual financial cost of the intervention
18 Conclusions (a) Considers overall practical usefulness of the intervention
(b) Suggests implications of this report for further studies of improvement interventions
Other information Were there other factors relevant to the conduct and interpretation of the study?
19 Funding Describes funding sources, if any, and role of funding organisation in design, implementation, interpretation and publication of study
*These guidelines provide a framework for reporting formal, planned studies designed to assess the nature and effectiveness of interventions to improve the quality and safety of
care. It may not always be appropriate or even possible to include information about every numbered guideline item in reports of original studies, but authors should at least consider
every item in writing their reports. Although each major section (that is, Introduction, Methods, Results and Discussion) of a published original study generally contains some
information about the numbered items within that section, information about items from one section (for example, the Introduction) is also often needed in other sections (for
example, the Discussion).
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contrast, are concerned with reporting studies in a defined
content area—improvement and safety. The two guideline
types are therefore complementary; when appropriate, other
specific design-related guidelines can and should therefore be
used in conjunction with SQUIRE.
Road testing
The editors of the journal Quality and Safety in Health Care
gained experience with the initial draft guidelines by using them
to help judge the completeness and transparency of submitted
manuscripts, and encouraging their use by authors in revising
their papers.
15–18 The guidelines were also used by authors
participating in the Academy for Healthcare Improvement’s
2007 scientific symposium in preparing their abstracts for
subsequent publication.
Formal commentaries
Written commentaries on the draft guidelines raised several
additional major points. On the one hand, the guidelines’ focus
on ‘‘pragmatic science’’ was seen as an important complement
to traditional experimental clinical science.
6 They were also seen
as a valuable instrument for strengthening the design and
conduct of improvement research, potentially leading to greater
synergy with improvement practice,
9 and for increasing the
feasibility of combining improvement studies in systematic
reviews. On the other hand, the commentaries identified a
number of potential difficulties: the draft guidelines were seen
as being inattentive to racial and ethnic disparities in care
8; their
IMRaD structure (Introduction, Methods, Results and
Discussion) was judged to be incompatible with the reality
that improvement interventions, by design, change over time
7;
and there was concern that their use could result in a ‘‘dumbing
down’’ of improvement science.
10
Health disparities
In our view, it would not be useful (even if it were possible) to
address every relevant content issue in a concise set of guidelines
for reporting improvement studies. We do agree, however, that
disparities in care are not considered often enough in improve-
ment work, and that improvement initiatives should address
this important issue whenever possible. We have therefore
specifically cited the issue of care disparities among important
outcomes to consider (table 1, item 13(b)(ii)).
The IMRaD structure
The Methods sections of scientific reports traditionally describe
study protocols that are rigidly fixed, as required by the dictates
of experimental design.
19 Improvement, in contrast, is a
‘‘reflexive’’ learning process—that is, improvement interven-
tions are most effective when they are modified over time in
response to outcome feedback. On those grounds, it has been
suggested that reporting improvement interventions in the
IMRaD format requires multiple sequential Methods sections,
one for each iteration of the evolving intervention.
7 This
apparent lack of fit between the realities of improvement
practice and the traditional reporting structure for experimental
studies has generated considerable debate, which remains
unresolved since a reasonable case can be made both for and
against use of the IMRaD structure. However, we continue to
argue that, as is true for all reports of scholarly inquiry,
20 reports
of improvement studies need to answer A Bradford Hill’s four
fundamental questions: Why did you start? What did you do?
What did you find? And what does it mean? In our view, that
generic requirement justifies using a single Methods section to
describe the initial improvement plan and the theory on which
it is based; the changes in interventions over time and the
learning that comes from making those changes then belong in
the Results section rather appearing than in a series of separate
Methods sections, since they are themselves important
improvement outcomes.
1
‘‘Dumbing down’’ improvement reports
The main declared purpose of all publication guidelines is to
improve the completeness and transparency of reporting. Since
it is precisely those characteristics of reporting that make it
possible to detect weak, sloppy, or poorly designed studies, it is
difficult to understand how use of the draft guidelines might
lead to a ‘‘dumbing down’’ of improvement science. The
underlying concern here apparently has less to do with
transparency, therefore, than with the inference that the draft
guidelines were seen as failing to require the rigorous standards
of evidence associated with true experimental and quasi-
experimental design.
19 We recognise the importance of those
standards in protecting the integrity of outcome measurements,
primarily by reducing selection bias
19 21; those standards,
however, fail to take into account the unique purpose and
characteristics of the improvement process.
Unlike the ‘‘conceptually neat and procedurally unambig-
uous’’ interventions—drugs, tests and procedures—whose
efficacy is traditionally studied in clinical research, improve-
ment is essentially a social process. Its immediate purpose is to
change human performance, and it is driven primarily by
experiential learning.
22 23 It is therefore inherently context
dependent and, as noted, reflexive; it is unstable; and it
generally involves complex, multi-component interventions.
Although traditional experimental and quasi-experimental
methods are clearly important for learning whether improvement
interventions change behaviour, they do not address the crucial
pragmatic (or ‘‘realist’’) questions about improvement: what is it
about the mechanism of a particular intervention that works,
for whom and under what circumstances?
24–26 Using methods that
will simultaneously answer all of these questions is not an easy
task, since the experimental and pragmatic approaches can
work at cross purposes. The SQUIRE guidelines attempt to
maintain an appropriate balance between these two crucial
methodologies.
Consensus meeting of editors and research scholars
With generous support from the Robert Wood Johnson
Foundation we undertook a critical appraisal of the draft
guidelines at a two-day meeting in April 2007. Thirty people,
including clinicians, improvement professionals, epidemiolo-
gists, clinical researchers and journal editors attended, several
from outside the United States. Before the meeting we sent
participants a reading list and a concept paper on the
epistemology of improvement. In plenary and small group
sessions, participants at the meeting critically discussed and
debated the content and wording of every item in the draft
guidelines, recommended changes and provided input on plans
for dissemination, adoption and future uses of the guidelines.
Working from transcribed audiorecordings of all meeting
sessions and flip charts listing the key discussion points, a
coordinating group (the authors of this paper, with important
administrative support from Joy McAvoy) then revised, refined
and expanded the draft guidelines.
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Following the consensus meeting, we circulated sequential
revisions of the guidelines for further comments and suggestions
in three cycles of a Delphi process. The group involved in that
process included the meeting participants plus roughly 20
additional expert consultants. All participants in this process
were then asked whether they would be willing to endorse the
final consensus version (SQUIRE).
Several features of SQUIRE are worth noting in particular.
First, it distinguishes clearly between the practice of improve-
ment (that is, the complex process of planning and implement-
ing improvement interventions) and the evaluation of those
interventions (that is, the equally complex process of designing
and executing formal studies to assess whether those interven-
tions work, and why they do or do not work). Second, SQUIRE
highlights the essential and unique properties of improvement
interventions, particularly their social nature, focus on changing
performance, context-dependence, complexity, non-linearity,
adaptation and reflexiveness. Third, this version specifies both
the elements of study design that assess whether improvement
interventions work (by minimising bias and confounding) and
the elements of methods that assess why interventions are or are
not effective (by marking out contexts and mechanisms of
change). And fourth, this version explicitly addresses the ethical
dimensions of improvement and improvement studies. Further
differences between the initial draft guidelines and the SQUIRE
guidelines are provided in table 2.
LIMITATIONS AND QUESTIONS
The SQUIRE guidelines have been characterised as providing
both too little and too much information: too little, because
they fail to represent adequately the many unique and nuanced
issues in the practice of improvement (for example, matching
system changes with the type of healthcare problem: simple,
complicated or complex),
27 or the details of experimental and
realist study methods
19 21 24–26; too much, because the detail and
density of the item descriptions can seem intimidating to
authors. Recognising the impossibility of characterising ade-
quately all the essentials of a specific study design or a domain
of inquiry in the item descriptions themselves, the developers of
several publication guidelines have created accompanying
‘‘Explanation and Elaboration’’ (E & E) documents that provide
much of the depth and detail that are missing from the
guidelines.
28–30 Building on this concept, the Medical Journal of
Australia published a series of analytical articles, each devoted to
an individual CONSORT guideline item, which were later
collected into a book.
31
That said, we recognise that the SQUIRE item descriptions
are significantly more detailed than those of some other
publication guidelines. In our view, the complexity of the
improvement process, plus the relative unfamiliarity of
improvement interventions and of the methods for evaluating
them, justifies that level of detail, particularly in light of the
enormously diverse backgrounds of people working to improve
health care. Moreover, the level of detail in the SQUIRE
Table 2 Key features of the SQUIRE guidelines that differ from the initial draft
SQUIRE section and item Added or changed feature of SQUIRE
Title and abstract Focuses on the accessibility/retrievability of your article
1 Title Specifies what is meant by improvement, aim of intervention, study methods
2 Abstract Separated from title; elaborates on abstract format
Introduction Focuses on the rationale of your study
3 Background knowledge Asks for characteristics of organisations in which the problem occurs
4 Local problem No change
5 Intended improvement More specific about improvement aim, plus what triggered the decision to make changes
6 Study question Distinguishes the study question from the aim of the improvement
Methods Focuses on what you did
7 Ethical issues Added item: addresses concrete ethical issues rather than administrative ethics review
8 Setting Highlights context features relevant to why an intervention succeeds
9 Planning the intervention Requests specifics on intervention components, factors in choice of the intervention, initial plans for implementation
10 Planning the study of the intervention Added item: separates study of the interventions from the improvement methods themselves; requests specifics on intervention dose
and mechanism, study design, issues of internal and external validity
11 Methods of evaluation Requests specifics on qualitative and quantitative methods; implementation effectiveness, mechanism, primary and secondary
outcomes; data quality
12 Analysis Requests specifics on qualitative and quantitative approaches; appropriateness of the unit of analysis; power
Results Focuses on what you found
13 Outcomes Includes characteristics of setting relevant to intervention mechanism; requests specifics on success of implementation, strength of
association between intervention and outcomes, missing data
Discussion Focuses on what your findings mean
14 Summary Highlights the study’s strengths
15 Relation to other evidence Suggests use of summary table of available published evidence
16 Limitations Requests specifics on maintenance of improvement and on challenges to internal and external validity
17 Interpretation Expands on the differences between observed and expected results; strength of the data; influence of context factors; modifications that
might increase the intervention’s effectiveness; opportunity and actual financial costs
18 Conclusions No change
Other information Focuses on factors external to the study itself that could affect findings and conclusions
19 Funding Requests specifics on funding sources and role of funders in conduct of the study
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observational studies, which also involve substantial complex-
ities of study design.
32 To minimise the difficulty of under-
standing and using the SQUIRE guidelines we do plan, however,
to make available a shortened electronic version, accompanied
by a glossary of terms that may be unfamiliar to potential users.
CURRENT AND FUTURE DIRECTIONS
In this supplement, we advance an E & E document that
provides the rationale for including the item in SQUIRE, as well
as examples of reporting practice for each guideline item, with
commentary on strengths and weaknesses of the examples.
33 To
increase the awareness of SQUIRE we are pursuing simulta-
neous print publication of the present article, as well as editorial
commentary on the article, in several journals, along with links
to an electronic version, as has been the practice with the public
release of other reporting guidelines. We are also promoting the
adoption of SQUIRE as journal editorial policy, and its use in
peer review and the editorial process.
The SQUIRE website (www.squire-statement.org) will pro-
vide an authentic electronic home for the guidelines themselves,
a medium for their progressive refinement and an electronic
community for authors, students, teachers, reviewers and
editors who are interested in the emerging body of knowledge
on improvement. Plans for the site include full and short
versions of SQUIRE; its accompanying E & E document;
commentaries; background readings on the epistemology and
science of improvement; a listserve; links to related sites (for
example, sites for other publication guidelines, articles that have
cited the initial draft guidelines or the SQUIRE version and the
like); an edited Wiki section made up of topic areas anchored in
SQUIRE; and perhaps a section where authors can post drafts of
manuscripts of improvement studies for critical peer review and
assessment before journal submission.
Although the primary purpose of SQUIRE is to improve the
reporting of original, data-driven improvement studies, we
believe the guidelines can also serve useful educational purposes,
particularly as a framework for understanding the epistemology
of improvement and the methodologies for evaluating improve-
ment work. We believe, similarly, that they can be helpful in
planning improvement interventions and studies of those
interventions, and therefore plan to support SQUIRE-related
educational efforts in those areas.
The value of publication guidelines has been assessed
primarily by measuring their impact on the completeness and
transparency of relevant publications.
34 35 Although such studies
are difficult, we will encourage and support efforts to evaluate
the impact of SQUIRE on the quality of the published
improvement literature. And, finally, since publication guide-
lines are only as strong as their constituent items, we will in
addition support efforts to provide empirical evidence that
individual guideline items contribute materially to the validity
and value of published information in improvement science.
Acknowledgements: We are grateful to R Gibson and L Leviton for their unflagging
support of this project, and to J McAvoy for her invaluable administrative work in
coordinating the entire SQUIRE development process. The following people contributed
critical input to the guidelines during their development: K Dickersin, D Goldmann, P
Goetzsche, G Guyatt, H Luft, K McPherson, V Montori, D Needham, D Neuhauser,K
Shojania, V Snow, E Wagner, V Weber.
The following participants in the consensus process also provided critical input on the
guidelines, and endorsed the final version. Their endorsements are personal, and do
not imply endorsement by any group, organisation or agency: D Aron, V Barbour, J
Berlin, S Berman, D Berwick, M Bisognano, A Booth, I Boutron, P Buerhaus, M Chin, B
Crabtree, L Cronenwett, M Dixon-Woods, B Doebbling, D Dougherty, M Eccles,S
Ellenberg, W Garrity, L Green, T Greenhalgh, L Headrick, S Horn, J Johnson, K Koplan,
D Korn, U Kotegal, S Landefield, E Loder, J Lynn, S Mallett, P Margolis, D Mason, D
Minckler, B Mittman, C Mulrow, E Nelson, P Plsek, P Pronovost, L Provost, P Ravaud, R
Resar, J Roessner, J-A Røttingen, L Rubenstein, H Sox, T Speroff, R Thomson, E von
Elm, E Wager, D Wakefield, B Weeks, H Williams, S Williams.
All authors contributed substantively to the ideas developed in the SQUIRE project, and
provided critical input on the guidelines themselves. FD, PB and DS were co-principal
investigators for the RWJF components of the project. FD drafted the paper, and
serves as the guarantor. All authors reviewed, commented on and approved the final
version of the paper.
Funding: The SQUIRE project was supported in part by a grant from the Robert Wood
Johnson Foundation (RWJF grant number 58073).
Competing interests: FD is editor emeritus of Annals of Internal Medicine and serves
currently as executive editor for the Institute for Healthcare Improvement, Cambridge,
Massachusetts, USA. PB is director of the Center for Leadership and Improvement at
the Dartmouth Institute for Health Policy and Clinical Practice at Dartmouth College,
Hanover, New Hampshire, USA; DS formerly served as vice president for healthcare
improvement and director of the Institute for Improving Clinical Care within the
Association of American Medical Colleges, Washington, DC, USA; he is currently
director of the Quality Literature Program at the Center for Leadership and
Improvement at the Dartmouth Institute for Health Policy and Clinical Practice; he is
also editor of the journal Quality and Safety in Health Care. GO is associate director of
the Quality Literature Program in the Center for Leadership and Improvement at the
Dartmouth Institute for Health Policy and Clinical Practice and director of the Office of
Research and Innovation at Medical Education at Dartmouth Medical School; he is also
on the clinical staff of the White River Junction Veterans Administration Hospital,
White River Junction, Vermont, USA. SM is medical director for quality improvement
at the Alice Peck Day Memorial Hospital, Lebanon, New Hampshire, and a member of
the staff of the Center for Leadership and Improvement in the Dartmouth Institute for
Health Policy and Clinical Practice, New Hampshire, USA.
Some of the work reported in this paper was done at the SQUIRE Advisory Committee
Meeting, 3–5 April 2007, which was supported in part by a grant from the Robert
Wood Johnson Foundation (RWJF grant number 58073).
REFERENCES
1. Davidoff F, Batalden P. Toward stronger evidence on quality improvement. Draft
publication guidelines: the beginning of a consensus project. Qual Saf Health Care
2005;14:319–25.
2. Boat TJ, Chao SM, O’Neill PH. From waste to value in health care. JAMA
2008;299:568–71.
3. Shojania K, Ranji SR, McDonald KM, et al. Effects of quality improvement strategies
for type 2 diabetes on glycemic control. A meta-regression analysis. JAMA
2006;296:427–40.
4. Janisse T. A next step: reviewer feedback on quality improvement publication
guidelines. Permanente J 2007;11:1.
Summary
c Published reports of medical quality improvement are
relatively few, and reporting is often inadequate.
c The SQUIRE guidelines presented here were developed to
encourage more and better reporting of formal improvement
studies.
c This paper describes the consensus process used to develop
the SQUIRE guidelines.
c The current paper also considers limitations, questions and
future directions of the SQUIRE project.
Linked information
c The EQUATOR Network. Enhancing the QUality And
Transparency Of health Research. Available at http://www.
equator-network.org
c The SQUIRE guidelines. Standards for QUality Improvement
Reporting Excellence. Available at http://www.squire-
statement.org
Supplement
i8 Qual Saf Health Care 2008;17(Suppl I):i3–i9. doi:10.1136/qshc.2008.0290665. EQUATOR Network. Enhancing the QUality And Transparency Of health Research.
http://www.equator-network.org (accessed 9 May 2008).
6. Berwick D. Broadening the view of evidence-based medicine. Qual Saf Health Care
2005;14:315–6.
7. Thomson RG. Consensus publication guidelines: the next step in the science of
quality improvement? Qual Saf Health Care 2005;14:317–8.
8. Chin MH, Chien AT. Reducing racial and ethnic disparities in health care: an integral
part of quality improvement scholarship. Qual Saf Health Care 2006;15:79–80.
9. Baker GR. Strengthening the contribution of quality improvement research to
evidence based health care. Qual Saf Health Care 2006;15:150–1.
10. Pronovost P, Wachter R. Proposed standards for quality improvement research and
publication: one step forward and two steps back. Qual Saf Health Care
2006;15:152–3.
11. Gawande A. The checklist. The New Yorker 2007;December 10:86–95.
12. Rennie D. Reporting randomized controlled trials. An experiment and a call for
responses from readers. JAMA 1995;273:1054–5.
13. Williams JW, Holleman JR, Samsa GP, et al. Randomized controlled trial of 3 vs 10
days of timethoprim/sulfamethoxazole for acute maxillary sinusitis. JAMA
1995;273:1015–21.
14. Rutledge A. On creativity. http://www.alistapart/articles/oncreativity (accessed 9
May 2008).
15. Stevens DP. Why new guidelines for reporting improvement research? And why
now? Qual Saf Health Care 2005;14:314.
16. Quality and Safety in Health Care. Guidelines for authors: guidelines for submitting
more extensive quality research. http://qshc.bmj.com/ifora/article_type.
dtl#extensive (accessed 1 July 2008).
17. Bechtold ML, Scott S, Nelson K, et al. Educational quality improvement report:
outcomes from a revised morbidity and mortality format that emphasized patient
safety. Qual Saf Health Care 2007;16:422–7.
18. Stevens DP, Andersson-Gare B. A proposal: publication guidelines for healthcare
improvement education reports. Qual Saf Health Care 2007;16:502–3.
19. Shadish WR, Cook TD, Campbell DT. Experimental and quasi-experimental designs
for generalized causal inference. New York: Houghton Mifflin, 2002.
20. Day RA. The origins of the scientific paper: the IMRaD format. J Am Med Writers
Assoc 1989;4:16–18.
21. Jadad AR, Enkin MW. Randomized controlled trials. Questions, answers, and
musings, 2 ed. London: Blackwell Publishing/BMJ Books, 2007.
22. Batalden P, Davidoff F. Teaching quality improvement. The devil is in the details.
JAMA 2007;298:1059–61.
23. Kolb DA. Experiential learning. Experience as the source of learning and
development. Englewood Cliffs, NJ: Prentice-Hall, 1984.
24. Pawson R, Greenhalgh T, Harvey G, et al. Realist review—a new method of
systematic review designed for complex policy interventions. J Health Serv Res Policy
2005;10(Suppl 1):21–34.
25. Pawson R, Tilley N. Realistic evaluation. Thousand Oaks, CA: Sage Publications,
1997.
26. Chelimsky E, Shadish WR, eds. Evaluation for the 21st century. A handbook.
Thousand Oaks, CA: Sage Publications, 1997.
27. Glouberman S. Foreword. In: Jadad AR, Enkin MW.Randomized controlled trials.
Questions answers, and musings, 2nd ed. London: Blackwell Publishing/BMJ Books,
2007:vi–ix.
28. Altman DG, Schulz KF, Moher D, et al. CONSORT Group (Consolidated Standards of
Reporting Trials). The revised CONSORT statement for reporting randomized trials:
explanation and elaboration. Ann Intern Med 2001;134:663–94.
29. Bossuyt PM, Reitsma JB, Bruns DE, et al. The STARD statement for reporting
studies of diagnostic accuracy: explanation and elaboration. Clin Chem 2003;49:7–
18.
30. Vandenbroucke JP, von Elm E, Altman DG, et al for the STROBE initiative.
Strengthening the reporting of observational studies in epidemiology (STROBE):
explanation and elaboration. Ann Intern Med 2007;147:W163–94.
31. Keech A, Gebski V, Pike R. Interpreting and reporting clinical trials. A guide to the
CONSORT statement and the principles of randomized trials. Sydney: Australian
Medical Publishing Company, 2007.
32. Von Elm E, Altman DG, Egger M, et al, for the STROBE initiative. The strengthening
the reporting of observational studies in epidemiology (STROBE) statement:
guidelines for reporting observational studies. Ann Intern Med 2007;147:573–7.
33. Ogrinc G, Mooney SE, Estrada C, et al. The SQUIRE (Standards for QUality
Improvement Reporting Excellence) guidelines for quality improvement reporting:
explanation and elaboration. Qual Saf Health Care 2008;17(Suppl 1):i13–i32.
34. Plint AC, Moher D, Morrison A, et al. Does the CONSORT checklist improve the
quality of reports of randomized controlled trials? A systematic review. Med J Aust
2006;185:263–7.
35. Egger M, Juni P, Bartlett C. Value of flow diagrams in reports of randomized
controlled trials. JAMA 2001;285:1996–9.
Supplement
Qual Saf Health Care 2008;17(Suppl I):i3–i9. doi:10.1136/qshc.2008.029066 i9